<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05072678</url>
  </required_header>
  <id_info>
    <org_study_id>29BRC21.0018 (MASTOS)</org_study_id>
    <nct_id>NCT05072678</nct_id>
  </id_info>
  <brief_title>Clinical and Radiological Evaluation of Two Mastoid Filling Products</brief_title>
  <acronym>MASTOS</acronym>
  <official_title>Clinical and Radiological Evaluation of Two Mastoid Filling Products in Patients With Cholesteratoma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      to compare, the osseous density in the mastoid of two products used to obliterate the mastoid&#xD;
      during surgery for cholesteatoma&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective: To compare the radiological aspect in the petrous bone of two obliteration&#xD;
      products in adults, one year after surgery (Bioactive Glass S53P4 and biological Hydroxy&#xD;
      apatite) secondary objective : To evaluate the cutaneous and the inner ear tolerance of&#xD;
      bioactive glass S53P4 and biological hydroxy apatite when used in the mastoid and epitympanic&#xD;
      obliteration for chronic otitis surgery&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 25, 2021</start_date>
  <completion_date type="Anticipated">April 25, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 25, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hounsfield Unit</measure>
    <time_frame>one year</time_frame>
    <description>The attenuation and osseointegration of the BG granules:&#xD;
The quantitative analysis included bone attenuation measurements (in Hounsfield units, HU) in the circular region of interest (34mm2) of BGand of surrounding cortical bone and otic capsule using the otic capsule adjacent to the LSCC and the posterior fossa dural plate (DP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>decibel</measure>
    <time_frame>one year</time_frame>
    <description>Auditory level pre and postoperative evaluation clinical</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>decibel</measure>
    <time_frame>one year</time_frame>
    <description>audiological evaluation</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Prospective Study</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with cholesteatoma surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult with cholesteatoma surgery Accepting the protocol and the radiological follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient less than 18 years old&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>remi Marianowski, MD, PhD</last_name>
    <phone>33298223333</phone>
    <phone_ext>CHU Brest</phone_ext>
    <email>remi.marianowski@chu-brest.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>sonia Sahli Vivi Corsi, MD</last_name>
    <phone>33298223052</phone>
    <email>soni.sahli@chu-brest.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU De Brest</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Remi Marianowski, MD,PhD</last_name>
      <phone>33298223333</phone>
      <email>remi.marianowski@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>September 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoingration</keyword>
  <keyword>surgery</keyword>
  <keyword>cholesteatome</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

